Generics in North America

Generics in North America

Summary

Generics in North America industry profile provides top-line qualitative and quantitative summary information including: market size (value 2018-23, and forecast to 2028). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

• A generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and branded generics are included in our market scope. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included. Market value is evaluated at ex-factory prices. Market volume refers to the proportion of the total ethical pharmaceutical market in a country or region that is made up of generic drugs. Thus, it is a measure of the market share held by generics, rather than a direct measure of the total market volume. Regional volumes are calculated as averages of countries that comprise the region where volume data exists.
• The North American generics market recorded revenues of $88.1 billion in 2023, representing a compound annual growth rate (CAGR) of 4.4% between 2018 and 2023.
• Market consumption volume increased with a CAGR of 0.8% between 2018 and 2023, to reach a total of 82.3% of total pharma volume in 2023.
• According to GlobalData, in 2023, the North American generics market grew by 4.5% annually. The growth is attributed to the region’s mounting aging population, with a high prevalence of chronic diseases such as hypertension, diabetes, and cardiovascular conditions.

• Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the generics market in North America
• Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in North America
• Leading company profiles reveal details of key generics market players’ global operations and financial performance
• Add weight to presentations and pitches by understanding the future growth prospects of the North America generics market with five year forecasts

• What was the size of the North America generics market by value in 2023?
• What will be the size of the North America generics market in 2028?
• What factors are affecting the strength of competition in the North America generics market?
• How has the market performed over the last five years?
• What are the main segments that make up North America's generics market?